A global decrease of DNA methylation has been detected in the hippocampus of AD patients [199], and histone hyperacetylation and DNA hypomethylation can increase APP and BACE1 transcription, possibly by activating NF-κB [200]. Here, NFKB1 is linked to Alzheimer disease.